Skip to main content

Corporate governance

Moberg Pharma has applied the Swedish Corporate Governance Code since May 26, 2011, the date when the company’s shares were listed on NASDAQ OMX Nordic Exchange Stockholm.

Corporate governance pertains to the regulatory framework and structure that have been established in order to effectively and in a controlled manner govern and manage the operations of a limited-liability company. The ultimate aim of corporate governance is to comply with the shareholders’ return requirements and the need of all stakeholders for information about the company and its development.

The management and control of Moberg Pharma is shared among the shareholders at the Annual General Meeting (AGM), the Board of Directors and the CEO in accordance with the Swedish Companies Act and the Articles of Association.

Corporate Governance Report 2018

Corporate Governance Report 2017

Corporate Governance Report 2016

Corporate Governance Report 2015

Corporate Governance Report 2014

Corporate Governance Report 2013